STOCK TITAN

Orbis, Allan Gray amend holdings in Genmab (GMAB) reporting 5.5% stake

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Genmab A/S ownership disclosure: two institutional investors filed an amended Schedule 13G/A reporting beneficial ownership positions in Genmab common stock. The filing shows 3,557,484 shares beneficially owned representing 5.5% of the class and identifies Orbis Investment Management Ltd and Allan Gray Australia Pty Ltd as the reporting persons.

The filing breaks the holdings down by voting and dispositive power: Orbis holds 3,549,674 shares with sole voting and dispositive power, and Allan Gray Australia holds 7,810 shares with sole voting and dispositive power. The filing states the reporting persons are non-U.S. institutions functionally equivalent to an investment adviser and disclaims group beneficial ownership.

Positive

  • None.

Negative

  • None.

Insights

Large passive stake reported by two non-U.S. institutions (5.5% combined).

The filing documents a combined 5.5% beneficial stake in Genmab common stock held by Orbis Investment Management Ltd and Allan Gray Australia Pty Ltd, with detailed breakdowns of sole voting and dispositive power. This indicates substantial institutional interest.

Key dependencies include any future amendments or sales filed by these holders; subsequent filings would show changes in position. The filing does not state trading intent or planned disposals.

Filing conforms to Schedule 13G/A disclosure for non-U.S. institutional investors.

The amendment classifies the reporting persons as Non-U.S. Institutions equivalent to investment advisers and includes a certification regarding a comparable foreign regulatory scheme. It disclaims group membership and provides signatures with attorney-in-fact attestations.

Material qualifiers include the functional equivalence statement and an offer to furnish Schedule 13D-level information on request; these preserve regulatory compliance without asserting additional rights or arrangements.

Beneficial ownership (combined) 3,557,484 shares Amount beneficially owned (Item 4(a))
Percent of class 5.5% Percent of class (Item 4(b))
Orbis sole voting power 3,549,674 shares Orbis sole power to vote and dispose (Item 4(c)(i)/(iii))
Allan Gray sole voting power 7,810 shares Allan Gray sole power to vote and dispose (Item 4(c)(i)/(iii))
Filer classification Non-U.S. Institution (FI) Declared equivalent to an Investment Adviser (IA)
Certification date (signature) 05/15/2026 Signature date for the amendment
beneficially owned regulatory
"Item 4(a) Amount beneficially owned: 3,557,484"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
sole dispositive power regulatory
"Orbis Investment Management Ltd - 3,549,674 sole dispositive power"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
Schedule 13G/A regulatory
"Amendment No. 2) GENMAB A/S Common Stock"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
Non-U.S. Institution (FI) regulatory
"classified as a Non-U.S. Institution (FI) that is equivalent to an Investment Adviser (IA)"





K3967W102

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



ORBIS INVESTMENT MANAGEMENT LTD
Signature:Matthew Gaarder
Name/Title:Attorney-in-Fact
Date:05/15/2026
Allan Gray Australia Pty Ltd
Signature:Matthew Gaarder
Name/Title:Attorney-in-Fact
Date:05/15/2026

FAQ

What stake in GENMAB does Orbis Investment Management report?

Orbis Investment Management reports beneficial ownership of 3,549,674 shares, which the filing lists as sole voting and dispositive power holdings.

What total percentage of Genmab does the Schedule 13G/A show?

The filing reports a combined beneficial ownership of 3,557,484 shares, representing 5.5% of the class of common stock.

How much does Allan Gray Australia hold in GENMAB according to this filing?

Allan Gray Australia Pty Ltd is reported to beneficially own 7,810 shares with sole voting and sole dispositive power.

Do the reporting persons claim to be a group under Section 13(d)?

No. The filing explicitly states neither reporting person represents it is a group under Section 13(d)(3) and each disclaims beneficial ownership of the other's shares.

What regulatory classification do the filers assert?

Both filers are classified as Non-U.S. Institutions (FI) equivalent to an Investment Adviser (IA), and they certify comparable foreign regulatory schemes.